Requirement of Corepressor Binding of Thyroid Hormone Receptor Mutants for Dominant Negative Inhibition
- 29 June 1998
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 247 (3) , 620-623
- https://doi.org/10.1006/bbrc.1998.8854
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Thyroid Hormone Resistance Syndrome Manifests as an Aberrant Interaction between Mutant T3 Receptors and Transcriptional CorepressorsMolecular Endocrinology, 1997
- A transcriptional co-repressor that interacts with nuclear hormone receptorsNature, 1995
- Ligand-independent repression by the thyroid hormone receptor mediated by a nuclear receptor co-repressorNature, 1995
- Site-directed mutagenesis of virtually any plasmid by eliminating a unique siteAnalytical Biochemistry, 1992
- Characterization of seven novel mutations of the c-erbA beta gene in unrelated kindreds with generalized thyroid hormone resistance. Evidence for two "hot spot" regions of the ligand binding domain.Journal of Clinical Investigation, 1991
- Thyroid hormone resistance syndrome. Inhibition of normal receptor function by mutant thyroid hormone receptors.Journal of Clinical Investigation, 1991
- Binding of 3,5,3′-Triiodothyronine (T3) and its Analogs to thein VitroTranslational Products of c-erbA Protooncogenes: Differences in the Affinity of the α- and β-Forms for the Acetic Acid Analog and Failure of the Human Testis and Kidney α-2 Products to Bind T3Molecular Endocrinology, 1990
- c-erbA Protooncogenes Mediate Thyroid Hormone-Dependent and Independent Regulation of the Rat Growth Hormone and Prolactin GenesMolecular Endocrinology, 1988